Does the anti-β2-glycoprotein I antibody provide additional information in patients with thrombosis?

The 1982 revised criteria for the classification of systemic lupus erythematosus

Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · see citing works

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409 · see citing works

Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants

Brandt, J. T., Barna, L. K., & Triplett, D. A. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649988 · Cited by 231 · see citing works

Antibodies to β2‐glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

Tsutsumi, A., Matsuura, E., Ichikawa, K., Fujisaku, A., Mukai, M., Kobayashi, S., & Koike, T. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390905 · Cited by 192 · see citing works

Thrombosis and Systemic Lupus Erythematosus: The Hopkins Lupus Cohort Perspective

Petri, M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069986 · Cited by 176 · see citing works

Association between the Prevalence of Antibodies to β2-Glycoprotein I, Prothrombin, Protein C, Protein S, and Annexin V in Patients with Systemic Lupus Erythematosus and Thrombotic and Thrombocytopenic Complications

Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y., & Kanakura, Y. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.6.1008 · Cited by 145 · see citing works

Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.

Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y., & Kanakura, Y. (2001) · PubMed · Cited by 136 · see citing works

A Prospective Epidemiological Study on the Occurrence of Antiphospholipid Antibody: The Montpellier Antiphospholipid (MAP) Study

Schved, J., DUPUYFONS, C., Biron, C., Quéré, I., & Janbon, C. (2009) · Haemostasis · doi:10.1159/000217099 · Cited by 104 · see citing works

Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.

Cabral, A. R., Cabiedes, J., & Alarcón-Segovia, D. (1995) · PubMed · Cited by 95 · see citing works

Value of autoantibodies to beta2-glycoprotein 1 in the diagnosis of antiphospholipid syndrome

AUDRAIN, M. A. P. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.5.550 · Cited by 40 · see citing works

ANTIPHOSPHOLIPID (HUGHES) SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS

Amigo, M., & Khamashta, M. A. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70141-1 · Cited by 39 · see citing works

Standardized measurement of major immunoglobulin class (IgG, IgA, and IgM) antibodies to β2glycoprotein I in patients with antiphospholipid syndrome

Lewis, S., KEIL, L. B., Binder, W. L., & DeBari, V. A. (1998) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(1998)12:5 · Cited by 35 · see citing works

Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I.

Tsutsumi, A., Ichikawa, K., Matsuura, E., Sawada, K., & Koike, T. (2000) · PubMed · Cited by 17 · see citing works

Untitled work

Wilson (1999) · doi:10.1002/1529-0131(199907)42:7

Untitled work

Atsumi (2000) · doi:10.1002/1529-0131(200009)43:9

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03674.x · Cited by 633 · see citing works

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Pengo, V., Ruffatti, A., Legnani, C., Testa, S., Fierro, T., Marongiu, F., De Micheli, V., Gresele, P., Tonello, M., Ghirarduzzi, A., et al. (2011) · Blood · doi:10.1182/blood-2011-03-340232 · Cited by 465 · see citing works

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Chaturvedi, S., Braunstein, E. M., Yuan, X., Yu, J. M., Alexander, A. A., Chen, H., Gavriilaki, E., Alluri, R. K., Streiff, M. B., Petri, M., et al. (2019) · Blood · doi:10.1182/blood.2019003863 · Cited by 231 · see citing works

How we diagnose the antiphospholipid syndrome

Giannakopoulos, B., Passam, F. H., Ioannou, Y., & Krilis, S. A. (2008) · Blood · doi:10.1182/blood-2007-12-129627 · Cited by 186 · see citing works

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

Ruffatti, A., Tonello, M., Del Ross, T., Cavazzana, A., Grava, C., Noventa, F., Tona, F., Iliceto, S., & Pengo, V. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0287 · Cited by 170 · see citing works

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

Tripodi, A., de Groot, P. G., & Pengo, V. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02362.x · Cited by 113 · see citing works

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Pengo, V., Banzato, A., Bison, E., Zoppellaro, G., Jose, S. P., & Denas, G. (2015) · Lupus · doi:10.1177/0961203315611495 · Cited by 90 · see citing works

Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome

Devreese, K., & Hoylaerts, M. F. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01243.x · Cited by 78 · see citing works

Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes

Yamada, H., Atsumi, T., Kobashi, G., Ota, C., Kato, E. H., Tsuruga, N., Ohta, K., Yasuda, S., Koike, T., & Minakami, H. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2008.11.001 · Cited by 76 · see citing works

Real world experience with antiphospholipid antibody tests: how stable are results over time?

Erkan, D., Derksen, W. J. M., Kaplan, V, Sammaritano, L., Pierangeli, S. S., Roubey, R., & Lockshin, M. D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.031856 · Cited by 76 · see citing works

Pregnancy loss and thrombophilia: the elusive link

Bennett, S. A., Bagot, C. N., & Arya, R. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09112.x · Cited by 75 · see citing works

Correct laboratory approach to APS diagnosis and monitoring

Pengo, V., Banzato, A., Denas, G., Jose, S. P., Bison, E., Hoxha, A., & Ruffatti, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.11.008 · Cited by 62 · see citing works

Clinical laboratory testing for the antiphospholipid syndrome

Pierangeli, S. S., & Harris, E. N. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.002 · Cited by 49 · see citing works

Anti-β2-glycoprotein I antibodies—When and how should they be measured?

Reber, G., & de Moerloose, P. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.034 · Cited by 40 · see citing works

Moderate versus high-titer persistently anticardiolipin antibody positive patients: Are they clinically different and does high-titer anti-β2-glycoprotein-I antibody positivity offer additional predictive information?

Erkan, D., Barbhaiya, M., George, D., Sammaritano, L. R., & Lockshin, M. (2009) · Lupus · doi:10.1177/0961203309355300 · Cited by 37 · see citing works

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio

Amory, C. F., Levine, S. R., Brey, R. L., Gebregziabher, M., Tuhrim, S., Tilley, B. C., Simpson, A.-C. C., Sacco, R. L., Mohr, J. P., & Collaborators, F. T. A.-W. (2015) · Cerebrovascular Diseases · doi:10.1159/000441362 · Cited by 31 · see citing works

The antiphospholipid triangle

Galli, M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03689.x · Cited by 29 · see citing works

The antiphospholipid syndrome

Pasquali, J., Poindron, V., Korganow, A., & Martin, T. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.08.008 · Cited by 28 · see citing works

Prevalence and Clinical Associations of Lupus Anticoagulant, Anticardiolipin Antibodies, and Anti-beta2-glycoprotein I Antibodies in Patients with Systemic Lupus Erythematosus

Woo, K., Kim, K.-E., Kim, J. M., Han, J., Chung, W., & Kim, K. (2010) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2010.30.1.38 · Cited by 27 · see citing works

An in-office wire-bending robot for lingual orthodontics.

Gilbert, A. (2011) · PubMed · Cited by 23 · see citing works

B cells in primary antiphospholipid syndrome: Review and remaining challenges

Dieudonné, Y., Guffroy, A., Poindron, V., Soulas-Sprauel, P., Martin, T., Korganow, A., & Gies, V. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102798 · Cited by 23 · see citing works

Accuracy of the First Fully Automated Method for Anti‐cardiolipin and Anti‐β2 Glycoprotein I Antibody Detection for the Diagnosis of Antiphospholipid Syndrome

Villalta, D., Alessio, M. G., Tampoia, M., Re, A., Stella, S., Re, M., Tozzoli, R., & Bizzaro, N. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04659.x · Cited by 22 · see citing works

Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome

Peterson, L. K., Willis, R., Harris, E. N., Branch, W. D., & Tebo, A. E. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.003 · Cited by 21 · see citing works

Treatment of the antiphospholipid syndrome

Galli, M. (2013) · Autoimmunity Highlights · doi:10.1007/s13317-013-0056-5 · Cited by 38 · see citing works

Chapter 2 Epidemiology of the Antiphospholipid Syndrome

Mehrani, T., & Petri, M. (2009) · Technical report · doi:10.1016/s1571-5078(08)00402-9 · Cited by 18 · see citing works

Women with unexplained recurrent pregnancy loss do not have evidence of an underlying prothrombotic state: Experience with calibrated automated thrombography and rotational thromboelastometry

Bennett, S. A., Bagot, C. N., Appiah, A., Johns, J., Ross, J. A., Roberts, L. N., Patel, R., & Arya, R. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.002 · Cited by 17 · see citing works

Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous Thromboembolism

Hirmerová, J., Ulcova-Gallova, Z., Seidlerová, J., Filipovský, J., Bibková, K., Mičanová, Z., & Mayer, O. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029608331228 · Cited by 17 · see citing works

Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers

Chaturvedi, S., & McCrae, K. R. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0668-2 · Cited by 16 · see citing works

The antiphospholipid antibody syndrome: diagnostic aspects

Behbehani, R. S., Sergott, R. C., & Savino, P. J. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000144389.97491.52 · Cited by 13 · see citing works

Antiphospholipid Antibodies: Laboratory and Pathogenetic Aspects

Vlachoyiannopoulos, P. G., Samarkos, M., Sikara, M. P., & Tsiligros, P. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360601079549 · Cited by 12 · see citing works

Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects

Vayá, A., Santaolaria, M., Micó, L., Calvo, J., Oropesa, R., Villa, P., Todolí, J., Simó, M., Corella, D., & Ricart, J. M. (2008) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2008-1117 · Cited by 10 · see citing works

The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies

Neville, C., Rauch, J., Kassis, J., Solymoss, S., Joseph, L., Bélisle, P., Subang, R., Chang, E. R., & Fortin, P. R. (2006) · Rheumatology · doi:10.1093/rheumatology/kel050 · Cited by 8 · see citing works

Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency Testing Program

Tebo, A. E., Rohan, W., Nwosu, A., Bashleben, C. P., Fox, D. A., Linden, M. A., & Karlon, W. J. (2023) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2023-0095-cp · Cited by 5 · see citing works

Phospholipid inhibitors

Galli, M. (2011) · Hämostaseologie · doi:10.5482/ha-1165 · Cited by 4 · see citing works

Reproductive Immunology and Its Disorders

Barrier, B. F., Gargiulo, A., & Schust, D. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00013-9 · Cited by 3 · see citing works

Evaluation of new commercial enzyme-linked immunosorbent assay kits in the laboratory diagnosis of antiphospholipid syndrome in view of the revised classification criteria of the antiphospholipid syndrome

Devreese, K. M. J. (2006) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000252600.09777.2b · Cited by 3 · see citing works

Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies

Pierangeli, S. S., & Rand, J. H. (2009) · Technical report · doi:10.1016/s1571-5078(08)00403-0 · Cited by 2 · see citing works

Management of immigration and pregnancy screening in northeastern Italy

Parco, S., & Tamaro (2011) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s16150 · Cited by 2 · see citing works

Quanto e come vengono applicate le linee guida in Autoimmunologia nei Laboratori italiani?

Porcelli, B., Cinquanta, L., Barberio, G., Sorrentino, M. C., Brusca, I., & Bizzaro, N. (2016) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-016-0134-6 · Cited by 2 · see citing works

Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome

Ruiz‐Irastorza, G., Pengo, V., Tektonidou, M. G., Ruiz‐Arruza, I., Cuadrado, M. J., & Khamashta, M. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3194-7_11 · Cited by 1 · see citing works

Antiphospholipid antibodies and lipoprotein(a) in obese children

Pascut, D., Princi, T., Donato, M., Tamaro, G., & Parco, S. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.01182.x

Laboratory Testing for Antiphospholipid Syndrome

Ioannou, Y., & Krilis, S. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10052-x

Prognosis in Antiphospholipid Syndrome

Serrano, R. M., Pons‐Estel, G., Espinosa, G., & Cervera, R. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00019-3

Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome

Amengual, O., Bertolaccini, M. L., & Atsumi, T. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00004-1

Antiphospholipid Syndrome Presented With Anterior Spinal Artery Syndrome

Kim, J.-H., Kim, Y. D., & Na, S.-J. (2012) · Journal of the Korean Neurological Association

Immunological investigation of the patient with renal disease

Berden, J. H. M., & Wetzels, J. F. M. (2015) · doi:10.1093/med/9780199592548.003.0017_update_001

The presence of IgG antibodies against β2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant

Rintelen, C., Vormittag, R., Sailer, T., Lehr, S., Quehenberger, P., Rumpold, H., Male, C., & Pabinger, I. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01394.x · Cited by 82 · see citing works

Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.

Lee, S., Cho, M. L., Joo, Y.-S., Kim, W. U., Hong, Y. S., Min, J., Lee, S. H., Park, S. H., Cho, C. S., & Kim, H. (2001) · PubMed · Cited by 41 · see citing works

Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

Viard, J., Amoura, Z., & Bach, J. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90049-h · Cited by 266 · see citing works

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170 · see citing works

β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219 · see citing works